Posted by Michael Wonder on 13 Jun 2019
Review of Rotarix
12 June 2019 - TLV has decided to initiate a review of the drug Rotarix due to the Government's decision that vaccines against rotavirus infection should be included in the vaccination program.
Decisions in the review will be made in August.
